Detalles de la búsqueda
1.
Six-year experience of Australia's first dedicated cancer of unknown primary clinic.
Br J Cancer
; 129(2): 301-308, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37225894
2.
Genomic Features and Classification of Homologous Recombination Deficient Pancreatic Ductal Adenocarcinoma.
Gastroenterology
; 160(6): 2119-2132.e9, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33524400
3.
Stroma vs epithelium-enhanced prognostics through histologic stratification in pancreatic ductal adenocarcinoma.
Int J Cancer
; 148(2): 481-491, 2021 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32955725
4.
Prognostic significance of postsurgery circulating tumor DNA in nonmetastatic colorectal cancer: Individual patient pooled analysis of three cohort studies.
Int J Cancer
; 148(4): 1014-1026, 2021 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32984952
5.
Circulating tumor DNA dynamics and recurrence risk in patients undergoing curative intent resection of colorectal cancer liver metastases: A prospective cohort study.
PLoS Med
; 18(5): e1003620, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33939694
6.
Characteristics and outcomes of participants in colorectal cancer biomarker trials versus a real-world cohort.
Acta Oncol
; 60(4): 482-490, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33377792
7.
Stage dependent recurrence patterns and post-recurrence outcomes in non-metastatic colon cancer.
Acta Oncol
; 60(9): 1106-1113, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34184594
8.
Real-world outcomes for neoadjuvant capecitabine versus infusional 5-fluorouracil in the treatment of locally advanced rectal cancer.
Intern Med J
; 51(8): 1262-1268, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32896960
9.
Immunohistochemical evaluation of the prognostic and predictive power of epidermal growth factor receptor ligand levels in patients with metastatic colorectal cancer.
Growth Factors
; 38(3-4): 127-136, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33775193
10.
Demonstrating the feasibility of collecting secondary, de-identified data on Australian patients receiving treatment as part of a Medicine Access Programme.
Intern Med J
; 50(1): 99-104, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30816606
11.
Utilisation of systemic therapy options in routine treatment of metastatic colorectal cancer in Australia.
Intern Med J
; 50(2): 165-172, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30887616
12.
Emerging biomarkers for immunomodulatory cancer treatment of upper gastrointestinal, pancreatic and hepatic cancers.
Semin Cancer Biol
; 52(Pt 2): 241-252, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29258858
13.
Emerging strategies in the initial management of locally advanced rectal cancer.
Future Oncol
; 15(25): 2955-2965, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31424262
14.
Chemotherapy and biologic use in the routine management of metastatic colorectal cancer in Australia: is clinical practice following the evidence?
Intern Med J
; 49(4): 446-454, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30230679
15.
Mismatch repair deficiency assessment by immunohistochemistry: for Lynch syndrome screening and beyond.
Future Oncol
; 14(26): 2725-2739, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-30004261
16.
Examining the impact of regular aspirin use and PIK3CA mutations on survival in stage 2 colon cancer.
Intern Med J
; 47(1): 88-98, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-27800646
17.
Analysis of local chronic inflammatory cell infiltrate combined with systemic inflammation improves prognostication in stage II colon cancer independent of standard clinicopathologic criteria.
Int J Cancer
; 138(3): 671-8, 2016 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26270488
18.
19.
Complete metabolic response following anaplastic lymphoma kinase (ALK) targeted therapy in a patient with adenocarcinoma of unknown primary with immunohistochemistry/fluorescence in situ hybridisation discordant ALK test results.
Intern Med J
; 51(8): 1355-1356, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34423539
20.
Impact of regular aspirin use on overall and cancer-specific survival in patients with colorectal cancer harboring a PIK3CA mutation.
Acta Oncol
; 54(4): 487-92, 2015 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-25549537